In addition, we could not prove the predictability of tumor-suppressive subtypes of peripheral CD8+ T cells (CD107a+, CD28+), while other studies demonstrated that a high frequency of CD8+ or CD8+CD28+ T cells predicted better prognosis [13, 15]. The gene discussed is CD8A; the disease is neoplasm.